{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"immunodeficiency-due-to-a-classical-component-pathway-complement-deficiency","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"Immunodeficiency due to a classical component pathway complement deficiency is a primary immunodeficiency due to a deficiency in either complement components C1q, C1r, C1s, C2 or C4 characterized by increased susceptibility to bacterial infections, particularly with encapsulated bacteria, and increased risk for autoimmune disease. Most commonly, these include systemic lupus erythematosus (SLE), SLE-like disease, Henoch-Schonlein purpura, polymyositis and arthralgia. Disease severity is variable and dependent on the complement affected.","mondoId":"MONDO:0015699","node":{"canonicalSlug":"immunodeficiency-due-to-a-classical-component-pathway-complement-deficiency","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Immunodeficiency due to a classical component pathway complement deficiency","originalSourceId":"ORPHA:169147","paragraphs":["Immunodeficiency due to a classical component pathway complement deficiency is a primary immunodeficiency due to a deficiency in either complement components C1q, C1r, C1s, C2 or C4 characterized by increased susceptibility to bacterial infections, particularly with encapsulated bacteria, and increased risk for autoimmune disease. Most commonly, these include systemic lupus erythematosus (SLE), SLE-like disease, Henoch-Schonlein purpura, polymyositis and arthralgia. Disease severity is variable and dependent on the complement affected."],"rawAttribution":"ORPHA:169147","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:56Z","upstream":"ORPHA:169147","url":"https://rarediseases.info.nih.gov/diseases/15025"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"complement deficiency","mondoId":"MONDO:0003832","slug":null},{"kind":"child","label":"complement component C1r/C1s deficiency","mondoId":"MONDO:0009005","slug":"complement-component-c1r-c1s-deficiency"},{"kind":"child","label":"complement component 2 deficiency","mondoId":"MONDO:0009006","slug":"complement-component-2-deficiency"},{"kind":"child","label":"C1Q deficiency","mondoId":"MONDO:0013343","slug":"c1q-deficiency"},{"kind":"child","label":"complement component C1s deficiency","mondoId":"MONDO:0013419","slug":"complement-component-c1s-deficiency"},{"kind":"child","label":"complement component 4b deficiency","mondoId":"MONDO:0013720","slug":"complement-component-4b-deficiency"},{"kind":"child","label":"complement component 4a deficiency","mondoId":"MONDO:0013721","slug":"complement-component-4a-deficiency"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/15025\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:169147</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Immunodeficiency due to a classical component pathway complement deficiency is a primary immunodeficiency due to a deficiency in either complement components C1q, C1r, C1s, C2 or C4 characterized by increased susceptibility to bacterial infections, particularly with encapsulated bacteria, and increased risk for autoimmune disease. Most commonly, these include systemic lupus erythematosus (SLE), SLE-like disease, Henoch-Schonlein purpura, polymyositis and arthralgia. Disease severity is variable and dependent on the complement affected.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/15025\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"immunodeficiency-due-to-a-classical-component-pathway-complement-deficiency","sourceDocuments":[{"name":"GARD: Immunodeficiency due to a classical component pathway complement deficiency","reviewed":null,"source_release":"2026-10-25T03:41:56Z","url":"https://rarediseases.info.nih.gov/diseases/15025"}],"sourceNote":"","synonyms":["immunodeficiency due to a C1, C4, or C2 component complement deficiency","immunodeficiency due to an early component of complement deficiency","immunodeficiency due to C1, C4, or C2 component complement deficiency"],"takeawayHtml":"","title":"immunodeficiency due to a classical component pathway complement deficiency"},"schemaVersion":1}
